PNS266 DIFFERENT INTERPRETATION OF ADDITIONAL EVIDENCE FOR HTA BY THE COMMISSIONED HTA BODY AND THE COMMISSIONING DECISION MAKER IN GERMANY: WHENEVER IQWIG AND FEDERAL JOINT COMMITTEE DISAGREE

Autor: Dintsios, C.M., Worm, F., Ruof, J., Herpers, M.
Zdroj: In Value in Health November 2019 22 Supplement 3:S807-S807
Databáze: ScienceDirect